Sujay Kango

Chief Executive Officer at Tmunity Therapeutics, Inc.

Net worth: - $ as of 2024-01-30

60 year

100 connections

Health Technology

Consumer Services

Health Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Justin File	M	53	MEI PHARMA, INC.	1 years
Tom Glocer	M	63	MERCK & CO., INC.	17 years
Rebecca Roberts	F	71	ABBVIE INC.	6 years
Carl June	M	70	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Melody Meyer	F	66	ABBVIE INC.	7 years
Dalton Smart	M	58	MERCK & CO., INC.	15 years
Chirfi Guindo	M	58	MERCK & CO., INC.	13 years
Denise Williams	F	-	MERCK & CO., INC.	15 years
James Flynn	M	43	MEI PHARMA, INC.	1 years
Caroline Ruiz	F	-	MEI PHARMA, INC.	2 years
Jason Sausser	M	-	MEI PHARMA, INC.	2 years
Steven Graziano	M	-	MERCK & CO., INC.	18 years
Taheer Mehboob Datoo	M	33	MEI PHARMA, INC.	1 years
Steven Wood	M	41	MEI PHARMA, INC.	1 years
Judith Li	F	40	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Pamela Eisele	F	-	MERCK & CO., INC.	15 years
Beth Seidenberg	M	67	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Sanat Chattopadhyay	M	-	MERCK & CO., INC.	15 years
Anne Frese	F	-	MEI PHARMA, INC.	2 years
Garry Nicholson	M	69	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 years
Patrick M. Gray	M	75	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 years
Jorge Conde	M	47	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 years
Sean Parker	M	44	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	6 years
Li Ming	M	-	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Lawrence Bloch	M	58	INFINITY PHARMACEUTICALS, INC.	11 years
N. Coles	M	63	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	5 years
Daniel Gold	M	70	MEI PHARMA, INC.	13 years
Fred Hassan	M	78	MERCK & CO., INC.	6 years
Brian Drazba	M	63	MEI PHARMA, INC.	6 years
Christine Anna White	M	72	MEI PHARMA, INC.	13 years
David J. Scott	M	71	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	-
Ofir Moreno	M	-	MEI PHARMA, INC.	12 years
Robert Iannone	M	57	MERCK & CO., INC.	6 years
Ismail Kola	M	67	MERCK & CO., INC.	4 years
Jaren Madden	F	-	INFINITY PHARMACEUTICALS, INC.	7 years
Tamar Howson	F	75	MEI PHARMA, INC.	4 years
Carole A. Sable	M	62	MERCK & CO., INC.	16 years
William Ringo	M	78	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 years
Thomas Robert Cech	M	76	MERCK & CO., INC.	-
Thomas Wiggans	M	72	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	8 years
Kenneth Bartizal	M	72	MERCK & CO., INC.	20 years
Wendy Yarno	F	69	MERCK & CO., INC.	9 years
Craig Thompson	M	71	MERCK & CO., INC.	10 years
Harry R. Jacobson	M	76	MERCK & CO., INC.	3 years
Vito Palombella	M	61	INFINITY PHARMACEUTICALS, INC.	12 years
Julie Gerberding	M	69	MERCK & CO., INC.	-
Gwen A. Fyfe	M	72	INFINITY PHARMACEUTICALS, INC.	4 years
Wendell Wierenga	M	76	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	17 years
Magnus Åke Lundberg	M	68	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	13 years
Paul Goddard	M	74	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	16 years
Cheryl L. Cohen	F	58	MEI PHARMA, INC.	2 years
Pablo Cagnoni	M	60	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 years
Carlos Eduardo Represas de Almeida	M	78	MERCK & CO., INC.	-
Leslie Brun	M	72	MERCK & CO., INC.	13 years
Caroline Dorsa	F	64	MERCK & CO., INC.	22 years
Richard Henriques	M	68	MERCK & CO., INC.	27 years
Natarajan Sethuraman	M	62	MERCK & CO., INC.	10 years
Antonio J. Grillo-López	M	84	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	11 years
Christopher M. Lindblom	M	52	INFINITY PHARMACEUTICALS, INC.	-
Helen Torley	M	61	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 years
Kevan E. Clemens	M	80	MEI PHARMA, INC.	7 years
Jean-Marie Canan	M	68	MERCK & CO., INC.	5 years
Eric S. Lander	M	67	INFINITY PHARMACEUTICALS, INC.	10 years
William N. Kelley	M	84	MERCK & CO., INC.	-
Sriram Ryali	M	43	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 years
Steven Goldstone	M	78	MERCK & CO., INC.	6 years
Samuel Agresta	M	51	INFINITY PHARMACEUTICALS, INC.	5 years
David Anstice	M	75	MERCK & CO., INC.	5 years
Christine Cioffe	F	-	MERCK & CO., INC.	20 years
Anastasia Daifotis	M	-	MERCK & CO., INC.	-
Wei Tang	M	-	MERCK & CO., INC.	15 years
Andrew Plump	M	58	MERCK & CO., INC.	-
Jens Renstrup	M	59	MERCK & CO., INC.	8 years
James F. Fuqua	M	-	MERCK & CO., INC.	31 years
Louisa Shaw-Marotto	F	56	MERCK & CO., INC.	3 years
Lu Amy Sun	M	67	MERCK & CO., INC.	7 years
Karen Ling	F	60	MERCK & CO., INC.	6 years
Maude Tessier	M	46	MERCK & CO., INC.	6 years
Barry Goldstein	M	-	MERCK & CO., INC.	5 years
Mark C. Twyman	M	63	MERCK & CO., INC.	18 years
Steven Hubrig Koehler	M	73	MERCK & CO., INC.	2 years
Kathleen Metters	M	66	MERCK & CO., INC.	13 years
Samuel O. Thier	M	86	MERCK & CO., INC.	16 years
Bradley Sheares	M	67	MERCK & CO., INC.	19 years
Richard Murray	M	65	MERCK & CO., INC.	5 years
Martin Duvall	M	62	MERCK & CO., INC.	1 years
Christina Morrison	F	57	MERCK & CO., INC.	4 years
David Mauro	M	59	MERCK & CO., INC.	7 years
Larry Bossidy	M	89	MERCK & CO., INC.	14 years
Judy Lewent	F	75	MERCK & CO., INC.	27 years
Margaret McGlynn	F	64	MERCK & CO., INC.	11 years
Eric Schadt	M	59	MERCK & CO., INC.	8 years
Per Wold-Olsen	M	76	MERCK & CO., INC.	32 years
C. Nicholson	M	68	MERCK & CO., INC.	2 years
Janelle Anderson	M	51	MERCK & CO., INC.	6 years
François Martelet	M	64	MERCK & CO., INC.	2 years
Deborah Law	M	-	MERCK & CO., INC.	4 years
Bruce A. Beutel	M	60	MERCK & CO., INC.	-
Aaron Dent	M	-	MERCK & CO., INC.	6 years
Jim Robinson	M	-	MERCK & CO., INC.	5 years

Statistics

Country	Connections	% of total
United States	100	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections